← All Sponsors
SPONSOR

AMO Pharma Limited

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Congenital Myotonic Dystrophy
NCT05004129 Phase 2, Phase 3
Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy

Congenital Myotonic Dystrophy
United States, Australia, Canada View Trial →